These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 39186847)
21. Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors. Unuvar A; Warrier I; Lusher JM Haemophilia; 2000 May; 6(3):150-7. PubMed ID: 10792472 [TBL] [Abstract][Full Text] [Related]
22. Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens. Lin PC; Liao YM; Tsai SP; Chang TT Pediatr Blood Cancer; 2011 Dec; 57(6):1029-33. PubMed ID: 21793191 [TBL] [Abstract][Full Text] [Related]
23. Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate. Oldenburg J; Jiménez-Yuste V; Peiró-Jordán R; Aledort LM; Santagostino E Haemophilia; 2014 Jan; 20(1):83-91. PubMed ID: 24354480 [TBL] [Abstract][Full Text] [Related]
24. Review of immune tolerance induction in hemophilia A. Schep SJ; Schutgens REG; Fischer K; Boes ML Blood Rev; 2018 Jul; 32(4):326-338. PubMed ID: 29482894 [TBL] [Abstract][Full Text] [Related]
25. F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis. Gouw SC; van den Berg HM; Oldenburg J; Astermark J; de Groot PG; Margaglione M; Thompson AR; van Heerde W; Boekhorst J; Miller CH; le Cessie S; van der Bom JG Blood; 2012 Mar; 119(12):2922-34. PubMed ID: 22282501 [TBL] [Abstract][Full Text] [Related]
26. Factor 8 (F8) gene mutation profile of Turkish hemophilia A patients with inhibitors. Fidanci ID; Kavakli K; Uçar C; Timur C; Meral A; Kilinç Y; Sayilan H; Kazanci E; Cağlayan SH Blood Coagul Fibrinolysis; 2008 Jul; 19(5):383-8. PubMed ID: 18600086 [TBL] [Abstract][Full Text] [Related]
27. Low-dose Immune Tolerance Induction in Hemophilia: A Single-Center Experience. Zulfikar B; Koc B; Ozdemir N J Pediatr Hematol Oncol; 2019 Aug; 41(6):e355-e358. PubMed ID: 31343592 [TBL] [Abstract][Full Text] [Related]
28. Predictors of the outcome of immune tolerance induction in patients with haemophilia A and inhibitors: The Brazilian Immune Tolerance (BrazIT) Study protocol. Camelo RM; Chaves DG; Zuccherato LW; Rezende SM; PLoS One; 2021; 16(8):e0256265. PubMed ID: 34437573 [TBL] [Abstract][Full Text] [Related]
29. Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study). Rocino A; Cortesi PA; Scalone L; Mantovani LG; Crea R; Gringeri A; ; Haemophilia; 2016 Jan; 22(1):96-102. PubMed ID: 26278414 [TBL] [Abstract][Full Text] [Related]
30. Immune tolerance induction in patients with hemophilia A. Astermark J Thromb Res; 2011 Jan; 127 Suppl 1():S6-9. PubMed ID: 21056905 [TBL] [Abstract][Full Text] [Related]
31. First report of molecular diagnosis of Tunisian hemophiliacs A: identification of 8 novel causative mutations. Elmahmoudi H; Khodjet-el-khil H; Wigren E; Jlizi A; Zahra K; Pellechia D; Vinciguerra C; Meddeb B; Elggaaied AB; Gouider E Diagn Pathol; 2012 Aug; 7():93. PubMed ID: 22883072 [TBL] [Abstract][Full Text] [Related]
32. Use of Haemate(®) P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational study. Rothschild C; D'Oiron R; Borel-Derlon A; Gruel Y; Navarro R; Negrier C Haemophilia; 2013 Mar; 19(2):281-6. PubMed ID: 23038998 [TBL] [Abstract][Full Text] [Related]
33. Analysis of F8 inversions as risk factors for FVIII inhibitor development in Indian severe haemophilia A patients. Pinto P; Ghosh K; Shetty S Blood Cells Mol Dis; 2014 Sep; 53(3):161-3. PubMed ID: 24824129 [TBL] [Abstract][Full Text] [Related]
34. Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study. Rivard GE; Rothschild C; Toll T; Achilles K Haemophilia; 2013 May; 19(3):449-55. PubMed ID: 23510123 [TBL] [Abstract][Full Text] [Related]
35. Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients. Gouw SC; Van Der Bom JG; Van Den Berg HM; Zewald RA; Ploos Van Amstel JK; Mauser-Bunschoten EP Haemophilia; 2011 Mar; 17(2):275-81. PubMed ID: 21070499 [TBL] [Abstract][Full Text] [Related]
36. Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units. Ter Avest PC; Fischer K; Gouw SC; Van Dijk K; Mauser-Bunschoten EP Haemophilia; 2010 May; 16(102):71-9. PubMed ID: 20536988 [TBL] [Abstract][Full Text] [Related]
37. The importance of inhibitor eradication in clinically complicated hemophilia A patients. Oldenburg J; Young G; Santagostino E; Escuriola Ettingshausen C Expert Rev Hematol; 2018 Nov; 11(11):857-862. PubMed ID: 30286680 [TBL] [Abstract][Full Text] [Related]
38. B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin. Biswas M; Palaschak B; Kumar SRP; Rana J; Markusic DM Front Immunol; 2020; 11():1293. PubMed ID: 32670285 [TBL] [Abstract][Full Text] [Related]
39. Inhibitors in haemophilia A: current management and open issues. Haya S; Moret A; Cid AR; Cortina V; Casaña P; Cabrera N; Aznar JA Haemophilia; 2007 Dec; 13 Suppl 5():52-60. PubMed ID: 18078398 [TBL] [Abstract][Full Text] [Related]
40. The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience. Kurth M; Puetz J; Kouides P; Sanders J; Sexauer C; Bernstein J; Gruppo R; Manco-Johnson M; Neufeld EJ; Rodriguez N; Wicklund B; Quon D; Aledort L J Thromb Haemost; 2011 Nov; 9(11):2229-34. PubMed ID: 21883884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]